Search

David G Matthes

from Avon, CT
Deceased

David Matthes Phones & Addresses

  • 114 Cold Spring Rd, Avon, CT 06001 (860) 673-7715
  • 3071 Sandpiper Bay Cir, Naples, FL 34112
  • 3071 Sandpiper Bay Cir #L205, Naples, FL 34112
  • 2667 River Reach Dr, Naples, FL 34104
  • San Francisco, CA
  • Alexandria, VA
  • Sarasota, FL
  • Saint Petersburg, FL

Resumes

Resumes

David Matthes Photo 1

Owner

View page
Location:
114 Cold Spring Rd, Avon, CT 06001
Industry:
Real Estate
Work:
Reagan Asset Management
Owner

Oncor International Feb 2003 - Mar 2007
President and Chief Executive Officer

Newport Partners Carter & Associates 1990 - 2001
Founding Partner

Tcc May 1987 - May 1991
Leasing and Market Manager
Education:
University of South Florida 1983 - 1987
Bachelors, Bachelor of Science, Business
Skills:
Multi Locationteam Management/Execution
Financial Controls/Oversight Development
Internal/External Market Share Development
Practice Area Team Development
Objective Based Technology Development
David Matthes Photo 2

David Matthes

View page

Publications

Us Patents

Semaphorin-Specific Antibodies

View page
US Patent:
6344544, Feb 5, 2002
Filed:
Apr 15, 1998
Appl. No.:
09/060610
Inventors:
Corey S. Goodman - Berkeley CA
Alex L. Kolodkin - Berkeley CA
David Matthes - Berkeley CA
David R. Bentley - Berkeley CA
Timothy OConnor - Berkeley CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 39395
US Classification:
5303879, 4241391
Abstract:
A novel class of proteins, semaphorins, nucleic acids encoding semaphorins, semaphorin peptides, and methods of using semaphorins and semaphorin-encoding nucleic acids are disclosed. Semaphorin peptides and receptor agonists and antagonists provide potent modulators of nerve cell growth and regeneration. The invention provides pharmaceutical compositions, methods for screening chemical libraries for regulators of cell growth/differentiation; semaphorin gene-derived nucleic acids for use in genetic mapping, as probes for related genes, and as diagnostic reagents for genetic neurological disease; specific cellular and animal systems for the development of neurological disease therapy.

Semaphorin Gene Family

View page
US Patent:
7153936, Dec 26, 2006
Filed:
Feb 4, 2002
Appl. No.:
10/067632
Inventors:
Corey S. Goodman - Berkeley CA, US
Alex L. Kolodkin - Berkeley CA, US
David Matthes - Berkeley CA, US
David R. Bentley - Berkeley CA, US
Timothy O'Connor - Berkeley CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C07K 1/00
C07K 14/00
A61K 38/00
US Classification:
530350, 530399, 435 691, 435 701
Abstract:
A novel class of proteins, semaphorins, nucleic acids encoding semaphorins, semaphorin peptides, and methods of using semaphorins and semaphorin-encoding nucleic acids are disclosed. Semaphorin peptides and receptor agonists and antagonists provide potent modulators of nerve cell growth and regeneration. The invention provides pharmaceutical compositions, methods for screening chemical libraries for regulators of cell growth/differentiation; semaphorin gene-derived nucleic acids for use in genetic mapping, as probes for related genes, and as diagnostic reagents for genetic neurological disease; specific cellular and animal systems for the development of neurological disease therapy.

Semaphorin Gene Family

View page
US Patent:
20070033669, Feb 8, 2007
Filed:
Oct 12, 2006
Appl. No.:
11/580373
Inventors:
Corey Goodman - Berkeley CA, US
Alex Kolodkin - Berkeley CA, US
David Matthes - Berkeley CA, US
David Bentley - Berkeley CA, US
Timothy O'Connor - Berkeley CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A01K 67/027
A61K 38/10
A61K 38/08
C07K 14/47
C12N 5/06
C07K 16/18
US Classification:
800018000, 530326000, 530327000, 530328000, 530329000, 530330000, 530388100, 435069100, 435320100, 435325000, 530350000, 514013000, 514014000, 514015000, 514016000, 514017000
Abstract:
A novel class of proteins, semaphorins, nucleic acids encoding semaphorins, semaphorin peptides, and methods of using semaphorins and semaphorin-encoding nucleic acids are disclosed. Semaphorin peptides and receptor agonists and antagonists provide potent modulators of nerve cell growth and regeneration. The invention provides pharmaceutical compositions, methods for screening chemical libraries for regulators of cell growth/differentiation; semaphorin gene-derived nucleic acids for use in genetic mapping, as probes for related genes, and as diagnostic reagents for genetic neurological disease; specific cellular and animal systems for the development of neurological disease therapy.

Semaphorin Gene Family

View page
US Patent:
20080312158, Dec 18, 2008
Filed:
Jun 14, 2007
Appl. No.:
11/763394
Inventors:
Corey S. Goodman - Berkeley CA, US
Alex L. Kolodkin - Berkeley CA, US
David Matthes - Berkeley CA, US
David R. Bentley - Berkeley CA, US
Timothy O'Connor - Berkeley CA, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA - Oakland CA
International Classification:
A61K 38/00
C07K 7/00
C07K 16/18
C12N 15/11
C12N 5/06
A61P 25/00
A01K 67/027
C12P 21/04
G01N 33/566
C12Q 1/68
US Classification:
514 16, 530330, 530329, 5303879, 536 235, 435352, 800 13, 435 691, 436501, 435 6, 514 17
Abstract:
A novel class of proteins, semaphorins, nucleic acids encoding semaphorins, semaphorin peptides, and methods of using semaphorins and semaphorin-encoding nucleic acids are disclosed. Semaphorin peptides and receptor agonists and antagonists provide potent modulators of nerve cell growth and regeneration. The invention provides pharmaceutical compositions, methods for screening chemical libraries for regulators of cell growth/differentiation; semaphorin gene-derived nucleic acids for use in genetic mapping, as probes for related genes, and as diagnostic reagents for genetic neurological disease; specific cellular and animal systems for the development of neurological disease therapy.

Semaphorin Gene Family

View page
US Patent:
59358653, Aug 10, 1999
Filed:
Apr 15, 1998
Appl. No.:
9/060692
Inventors:
Corey S. Goodman - Berkeley CA
Alex L. Kolodkin - Berkeley CA
David Matthes - Berkeley CA
David R. Bentley - Berkeley CA
Timothy O'Connor - Berkeley CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
G01N 33566
US Classification:
436501
Abstract:
A novel class of proteins, semaphorins, nucleic acids encoding semaphorins, semaphorin peptides, and methods of using semaphorins and semaphorin-encoding nucleic acids are disclosed. Semaphorin peptides and receptor agonists and antagonists provide potent modulators of nerve cell growth and regeneration. The invention provides pharmaceutical compositions, methods for screening chemical libraries for regulators of cell growth/differentiation; semaphorin gene-derived nucleic acids for use in genetic mapping, as probes for related genes, and as diagnostic reagents for genetic neurological disease; specific cellular and animal systems for the development of neurological disease therapy.

Semaphorin Gene Family

View page
US Patent:
58078266, Sep 15, 1998
Filed:
Apr 8, 1997
Appl. No.:
8/835268
Inventors:
Corey S. Goodman - Berkeley CA
Alex L. Kolodkin - Berkeley CA
David Matthes - Berkeley CA
David R. Bentley - Berkeley CA
Timothy O'Connor - Berkeley CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 3804
A61K 3816
US Classification:
514 12
Abstract:
A novel class of proteins, semaphorins, nucleic acids encoding semaphorins, semaphorin peptides, and methods of using semaphorins and semaphorin-encoding nucleic acids are disclosed. Semaphorin peptides and receptor agonists and antagonists provide potent modulators of nerve cell growth and regeneration. The invention provides pharmaceutical compositions, methods for screening chemical libraries for regulators of cell growth/differentiation; semaphorin gene-derived nucleic acids for use in genetic mapping, as probes for related genes, and as diagnostic reagents for genetic neurological disease; specific cellular and animal systems for the development of neurological disease therapy.

Semaphorin Gene Family

View page
US Patent:
56398565, Jun 17, 1997
Filed:
Sep 13, 1993
Appl. No.:
8/121713
Inventors:
Corey S. Goodman - Berkeley CA
Alex L. Kolodkin - Berkeley CA
David Matthes - Berkeley CA
David R. Bentley - Berkeley CA
Timothy O'Connor - Berkeley CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 3804
A61K 3816
C07K 14005
C07K 14435
US Classification:
530326
Abstract:
A novel class of proteins, semaphorins, nucleic acids encoding semaphorins, semaphorin peptides, and methods of using semaphorins and semaphorin-encoding nucleic acids are disclosed. Semaphorin peptides and receptor agonists and antagonists provide potent modulators of nerve cell growth and regeneration. The invention provides pharmaceutical compositions, methods for screening chemical libraries for regulators of cell growth/differentiation; semaphorin gene-derived nucleic acids for use in genetic mapping, as probes for related genes, and as diagnostic reagents for genetic neurological disease; specific cellular and animal systems for the development of neurological disease therapy.

Semaphorin Gene Family

View page
US Patent:
60137819, Jan 11, 2000
Filed:
Apr 8, 1997
Appl. No.:
8/833391
Inventors:
Corey S. Goodman - Berkeley CA
Alex L. Kolodkin - Berkeley CA
David Matthes - Berkeley CA
David R. Bentley - Berkeley CA
Timothy O'Connor - Berkeley CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C07H 2104
C12N 1511
US Classification:
536 231
Abstract:
A novel class of proteins, semaphorins, nucleic acids encoding semaphorins, semaphorin peptides, and methods of using semaphorins and semaphorin-encoding nucleic acids are disclosed. Semaphorin peptides and receptor agonists and antagonists provide potent modulators of nerve cell growth and regeneration. The invention provides pharmaceutical compositions, methods for screening chemical libraries for regulators of cell growth/differentiation; semaphorin gene-derived nucleic acids for use in genetic mapping, as probes for related genes, and as diagnostic reagents for genetic neurological disease; specific cellular and animal systems for the development of neurological disease therapy.

Isbn (Books And Publications)

Problems And Solutions For Strachan And Read's Human Molecular Genetics 3

View page
Author

David Matthes

ISBN #

0815341938

David G Matthes from Avon, CTDeceased Get Report